Congratulations to our Founder, President and CEO, Dun Yang, Ph.D. who has been named an In Vivo Rising Leader 2022. @INVIVOnow's 30 Rising Leaders recognize entrepreneurs and innovators who represent the next wave of creativity in health care.
Read more:https://t.co/moT9fKxuwS
Thanks to @conscienceteam and to @mrssuecharles and the team at Scius Communications for working so hard to make this happen. Thanks to @robjanoff for the amazing illustrations. We are very proud of our new website!
Check out our new beautiful website at https://t.co/Xs4DlZoXjl!
The new site provides deeper background on our vision and heritage, and full details on our discovery platforms, unique natural products and chemical libraries, and 5 discovery programs based on #syntheticlethality.
We are looking forward to attending #AACR21 this weekend. Do use the networking module to connect with us, if you'd like to learn more about our innovations in #MYC and #SyntheticLethality as novel approaches to treating #cancer or follow us to keep up to date with our news!
The #AACR21 Discovery Science Plenary— Mechanisms, Impact, and Exploitation of Cancer Chromosomal Instability— begins at 9:30 AM EDT today. Read a preview in AACR News:
https://t.co/BiiDFHKnwX
Identified a novel synthetic lethal interaction between ROCK inhibitor, diMF & overexpression of MYC suggesting repurposing diMF in treating MYC overexpressing tumors
@Thaddeus Allen @Dun Yang @Jing Zhang https://t.co/xAKO0UkMFM
#Syntheticlethality#MYC#Oncology#Drugdiscovery